Check-Cap (NASDAQ:CHEK) Stock Price Crosses Below 50 Day Moving Average – Time to Sell?

Check-Cap Ltd. (NASDAQ:CHEK) shares crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.60 and traded as low as $1.50. Check-Cap shares last traded at $1.6150, with a volume of 58,962 shares traded.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Check-Cap in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Check-Cap to a “hold” rating in a research report on Saturday, November 15th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Check-Cap presently has an average rating of “Sell”.

Check-Cap Stock Performance

The company’s 50 day moving average price is $1.60 and its 200 day moving average price is $1.23. The company has a market cap of $9.45 million, a price-to-earnings ratio of -0.58 and a beta of 0.41.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.